EMBO Molecular Medicine (Jul 2022)

Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination

  • Sebastian J Theobald,
  • Alexander Simonis,
  • Julie M Mudler,
  • Ulrike Göbel,
  • Richard Acton,
  • Viktoria Kohlhas,
  • Marie‐Christine Albert,
  • Anna‐Maria Hellmann,
  • Jakob J Malin,
  • Sandra Winter,
  • Michael Hallek,
  • Henning Walczak,
  • Phuong‐Hien Nguyen,
  • Manuel Koch,
  • Jan Rybniker

DOI
https://doi.org/10.15252/emmm.202215888
Journal volume & issue
Vol. 14, no. 8
pp. 1 – 15

Abstract

Read online

Abstract Durable cell‐mediated immune responses require efficient innate immune signaling and the release of pro‐inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS‐CoV‐2 mRNA vaccination primes human monocyte‐derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3‐driven pyroptotic cell death and subsequently secrete mature interleukin‐1β. These effects depend on activation of spleen tyrosine kinase (SYK) coupled to C‐type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage‐driven activation of effector memory T cells. Furthermore, vaccination‐induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime‐boost concepts to augment innate immune signaling in SARS‐CoV‐2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate spike protein‐specific T cell responses.

Keywords